CRP and thrombocytosis disease: Also, as regards the laboratory results, the methylprednisolone limb showed a decrease in the CRP level and thrombocytosis, although the dose and duration of methylprednisolone administration were different from our study, but their results are concordant with our results which revealed a dramatic beneficial effect in the methylprednisolone infusion at a dose of 2 mg/kg/day as regards the clinical status, radiologically by computed tomography HRCT, inflammatory cytokine storm markers, weaning from mechanical ventilation, and length of stay ICU as well as the ICU mortality.